Work

The mTOR inhibitor rapamycin opposes carcinogenic changes to epidermal Akt1/PKBα isoform signaling

Year: 2012

Type: article

Source: Oncogene

DOI: 10.1038/onc.2012.338

Authors: K Sully, O Akinduro, M P Philpott, A S Naeem, C A Harwood, V E Reeve, R F O'Shaughnessy, C Byrne

Institutions: University of London, Queen Mary University of London, Blizard Institute, University College London, The University of Sydney

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Cancer Research UK

Award: G8822966106

OpenAlex ID: W2000922399

FWCI: 0.839

Cites: 64

Cited by: 30

Related to: 10